Datavant – Ciox Health Merger to Lead to Improved Patient Outcomes

Datavant, the leader in helping healthcare organizations securely connect their data, and Ciox Health, the leader in clinical data exchange, have signed a definitive agreement to merge the two companies in a transaction valued at $7.0 billion.

The combined entity, to be named Datavant, will be the nation’s largest health data ecosystem, enabling patients, providers, payers, health data analytics companies, patient-facing applications, government agencies, and life science companies to securely exchange their patient-level data.

The combined company is focused on improving patient outcomes and reducing costs by removing impediments to the secure exchange of health data. Datavant will offer the ability to access, exchange, and connect data among the thousands of organizations in its ecosystem for use cases ranging from better clinical care and value-based payments, to health analytics and medical research.

Roivant Sciences, a global healthcare company, in 2017 launched of Datavant, a new company focused on employing artificial intelligence to improve the clinical trial process.

Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of de-identified patient records across datasets

Datavant’s patient support platform offers patient-centric capabilities in order to provide better services that improve patient outcomes for specialty drugs.

The Ciox platform leverages the industry’s most extensive clinical data network to connect data, improve patient outcomes, and lower healthcare costs. Ciox simply and securely connects healthcare decision makers with the data and hidden insights in patient medical records.


Takeaway: Specialty patient solution platforms support programs that serve as a key resource for patients beginning a specialty therapy